Matthew Charles Mulvey
Chief Executive Officer at BeneVir Biopharm, Inc.
Network origin in Matthew Charles Mulvey first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
BeneVir Biopharm, Inc.
 BeneVir Biopharm, Inc. BiotechnologyHealth Technology BeneVir Biopharm, Inc. develops oncolytic immunotherapies software for advanced solid tumors. It offers oncolytic immunotherapy, that attacks and kill cancer cells. The company was founded by Katherine Sacksteder, Matthew Charles Mulvey and Ian Mohr in 2011 and is headquartered in Rockville, MD.
4
| Subsidiary | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Matthew Charles Mulvey via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Sequella, Inc.
 Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Triple Ring Technologies, Inc.
 Triple Ring Technologies, Inc. Medical SpecialtiesHealth Technology Triple Ring Technologies, Inc. operates as an imaginative research and development firm. It works across the development process in regulated markets including medical devices, in vitro diagnostics and life science tools, imaging and industrial applications. The company was founded in February 2005 and is headquartered in Newark, CA. | Medical Specialties | Director/Board Member | |
R2 Technologies, Inc. (California)
 R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology R2 Technologies, Inc. is an American California-based company founded in 2014 by Irina Erenburg. The company specializes in developing groundbreaking technology that fights inflammation and provides precision cold treatment for the face and skin. The company's technology has been proven effective and is available for use in medical practices. The CEO is Tim Holt. | Medical Specialties | Director/Board Member | |
MediBeacon, Inc.
 MediBeacon, Inc. Medical SpecialtiesHealth Technology MediBeacon, Inc. provides optical diagnostic products and services. It offers Optical Renal Function Monitor, a platform focused on kidney function monitoring in real-time at the point-of-care. The company was founded by Steven J. Hanley and Richard B. Dorshow in 2012 and is headquartered in St. Louis, MO. | Medical Specialties | Director/Board Member |
Statistics
International
| United States | 5 |
Sectoral
| Health Technology | 5 |
Operational
| Director/Board Member | 5 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Chief Operating Officer | 1 |
Most connected contacts
- Stock Market
- Insiders
- Matthew Charles Mulvey
- Company connections
